4th Quarter - Report
BROWN RUDNICK LLP for HOSPIRA, INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen. Stabenow (05-07) |
| HENRY W MENN | CoS, Sen. Bob Graham (01 - 04) |
Pharmacy PHA
Issues relating to opioid abuse and drug shortages; Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen. Stabenow (05-07) |
| HENRY W MENN | CoS, Sen. Bob Graham (01 - 04) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.